Antibiotice (BSE:ATB) FFO


BSE:ATB Antibiotice SA BSE:ATB
75 GF Score
Price lei2.12
GF Value lei2.19
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Antibiotice FFO?

FFO (Funds from operations) only applies to REITs.

BSE:ATB
75GF Score
Antibiotice SA BSE:ATB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Antibiotice (BSE:ATB) Overvalued in 2026?

Based on GuruFocus' analysis, Antibiotice stock appears to be undervalued. The current stock price of lei2.12 is trading 3.4% below its estimated GF Value™ of lei2.19. GuruFocus considers Antibiotice to be Fairly Valued.

Key valuation signals for BSE:ATB:

  • FFO:
  • GF Value™: lei2.19 vs. price of lei2.12 (3.4% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the BSE:ATB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Antibiotice Business Description

Address 1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice SA is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
75GF Score

Get the complete analysis for BSE:ATB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei2.12
Price
lei2.19
GF Value